title: Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
authors.affiliation: University of Texas M.D. Anderson Cancer Center, Genitourinary Medical Oncology, Houston, TX 77030, USA.
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Richey
authors.forename: Priya
authors.initials: P
authors.lastname: Rao
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Wood
authors.forename: Shreyaskumar
authors.initials: S
authors.lastname: Patel
authors.forename: Nizar M
authors.initials: NM
authors.lastname: Tannir
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D060828:Induction Chemotherapy; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary; D008207:Lymphatic Metastasis; D060046:Maintenance Chemotherapy; D008297:Male; D008875:Middle Aged; D018242:Neuroectodermal Tumors, Primitive / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary; D011859:Radiography; D012512:Sarcoma, Ewing / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin; D007069:Ifosfamide